2,4-diaminobutyric acid has been researched along with EHS Tumor in 2 studies
2,4-diaminobutyric acid: RN given refers to parent cpd without isomeric designation
2,4-diaminobutyric acid : A diamino acid that is butyric acid in which a hydrogen at position 2 and a hydrogen at position 4 are replaced by amino groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sjölander, U | 1 |
| Ronquist, G | 2 |
| Hugosson, R | 2 |
| Westermark, B | 1 |
2 other studies available for 2,4-diaminobutyric acid and EHS Tumor
| Article | Year |
|---|---|
Naloxone as an adjuvant in chemotherapy of an experimental tumor.
Topics: Aminobutyrates; Animals; Drug Therapy, Combination; Male; Mice; Mice, Inbred Strains; Naloxone; Sarc | 1984 |
Antitumor activity of L-2,4 diaminobuturic acid against mouse fibrosarcoma cells in vitro and in vivo.
Topics: Aminobutyrates; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Fibrosarcoma; Male; Mice | 1980 |